Full-Stack Biomanufacturing Platform
GeisterBio builds the manufacturing stack for living tissues: hardware, biomaterials, perfusion workflows, software and QC designed to work together from print to measurement.
This is already more than a vision.
GeisterBio has already built its Gen1 platform, delivered the first external system, and demonstrated cm-scale flushing and perfusion workflows on printed constructs.
One platform. Staged commercialization.
Platform products and services first, LiverCube decision packages for pharma next, and patient-matched hearts long term. Same platform and workflow, multiple value drivers.
Platform Products & Services
Built systems, service and support, consumables, and application-specific platform work. Layer 1 commercialization is already real through external deployment and first platform revenue.
LiverCube Decision Packages
Perfused liver tissue models for drug safety and translational decisions. Customers buy a decision package, not a cube: study scope, tissue workflow, measurements, QC and interpretation.
Patient-matched Hearts
Same platform and workflow, multiple value drivers. The workflow that supports pharma decision packages today compounds toward patient-matched hearts as the long-term North Star.
Hardware. Software. Biology.
Built end-to-end.
Built around a patent-pending multi-material printhead and an integrated workflow for perfusion, maturation, QC and traceability. The stack is designed to print, perfuse, mature, measure, QC and trace living tissues as one controlled workflow.
Bioprinting
Patent-pending multi-material printhead with nozzle-to-nozzle switching in under one second. Modular architecture configurable from 4 to 32 separate extruders.
Perfusion
Controlled flushing and perfusion workflows that turn printed channels into perfusable tissue architectures, with QC gates and traceable process data.
Bioinks & Biomaterials
Cell-compatible bioinks and support materials designed for complex geometry, perfusion workflows and tissue-specific tuning.
Vascularization Algorithm
Computational geometry for vascular layouts that support perfusion and diffusion-aware tissue design.
AI Autonomy
Software and data capture for repeatability, QC, traceability and future AI-guided operation.
Perfused tissue models for pharma today. Building toward patient-matched hearts.
GeisterBio starts with perfused tissue models for pharma decisions. The same workflow spine compounds toward organ-scale therapeutic ambition without claiming near-term clinical readiness.
Lean core team. Full-stack execution.
Biology, hardware, software, design and company-building experience, executing with strong drive and capital efficiency.
Medical Biologist (B.Sc.). Leads full-stack tissue engineering, platform development and company strategy.
Software Engineer (M.Sc., Data Science & AI). Builds software systems, workflow logic and the AI/software layer.
Fractional CFO. Helped launch 300+ startups and raised $100M+ in venture funding across his portfolio.
Computational Designer (B.Sc.). Implements complex multi-level and multi-material design workflows end-to-end.
Strategic advisors across regenerative medicine, regulatory science, clinical translation and commercialization.
Active expertise where it matters most.
Former CEO & co-founder of ProKidney. Regenerative medicine and commercialization leader.
Academic and manufacturing innovation leader at North Carolina A&T State University.
Regenerative medicine ecosystem builder and strategic connector.
Regulatory science advisor and former FDA CBER / OTAT branch chief.
Cardiac surgery and clinical translation advisor.
Request materials or get in touch.
Whether you are an investor, pharma or CRO partner, research collaborator, strategic/OEM contact or press representative, use the form below and we will follow up directly.